Science and Technology
At GenoCure.AI, cutting-edge technology meets deep biological insights to redefine the landscape of precision medicine.
Our proprietary methodologies leverage advanced computational models, DNA and RNA sequencing, and vast biological datasets to uncover hidden therapeutic opportunities. By integrating AI-driven analysis with real-world clinical data, we provide pharmaceutical companies and healthcare providers with actionable insights that optimize treatment strategies and improve patient outcomes.
TVA
The Therapeutic Variant Assessment (TVA) method is a DNA-based approach that systematically ranks all mutations, including those classified as Variants of Uncertain Significance (VUS).
TVA applies a novel quantitative framework to evaluate the selective advantage of somatic point mutations, providing a prioritized view of potentially impactful variants.
This approach aims to enhance the identification of key driver mutations, supporting more precise therapeutic decision-making and expanding the understanding of mutational landscapes in oncology.
MESiCA
Multi-Element Synergistic Combination Analysis (MESiCA) is an advanced deep-learning algorithm designed to detect and quantify mutational signatures using gene panel data.
MESiCA enables the identification of mutational processes influencing cancer progression and drug response, offering insights that go beyond traditional sequencing analysis.
By integrating machine-learning-driven mutational embedding, MESiCA enhances precision oncology by uncovering previously unrecognized biomarker patterns that inform therapeutic decision-making and drug development.
STAMP
Systematic Targeted Analysis for Molecular Profiling (STAMP) is an RNA-based analytical framework utilizing 296 distinct AI-driven models to decipher the functional state of tumors.
STAMP utilizes graph-based neural networks to analyze transcriptomic activity, identifying key biological processes that shape treatment responses.
By capturing the dynamic interactions within the tumor microenvironment, STAMP refines patient stratification and aids in selecting the most effective therapeutic interventions, bringing unprecedented precision to oncology treatment.